Global Biotechnological Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Biotechnological Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Biotechnological Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biotechnological Drugs market. Biotechnological Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biotechnological Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biotechnological Drugs market.
Biotechnological Drugs, also known as biologics, are pharmaceutical products derived from living organisms using biotechnology techniques. These drugs can include vaccines, monoclonal antibodies, and gene therapies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Biotechnological Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biotechnological Drugs market. It may include historical data, market segmentation by Type (e.g., Genetically Engineered Drugs, Therapeutic Monoclonal Antibody Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biotechnological Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biotechnological Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biotechnological Drugs industry. This include advancements in Biotechnological Drugs technology, Biotechnological Drugs new entrants, Biotechnological Drugs new investment, and other innovations that are shaping the future of Biotechnological Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biotechnological Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Biotechnological Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biotechnological Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biotechnological Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biotechnological Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biotechnological Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biotechnological Drugs market.
Market Segmentation:
Biotechnological Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Biotechnological Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Biotechnological Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biotechnological Drugs market. Biotechnological Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biotechnological Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biotechnological Drugs market.
Biotechnological Drugs, also known as biologics, are pharmaceutical products derived from living organisms using biotechnology techniques. These drugs can include vaccines, monoclonal antibodies, and gene therapies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Biotechnological Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biotechnological Drugs market. It may include historical data, market segmentation by Type (e.g., Genetically Engineered Drugs, Therapeutic Monoclonal Antibody Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biotechnological Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biotechnological Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biotechnological Drugs industry. This include advancements in Biotechnological Drugs technology, Biotechnological Drugs new entrants, Biotechnological Drugs new investment, and other innovations that are shaping the future of Biotechnological Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biotechnological Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Biotechnological Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biotechnological Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biotechnological Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biotechnological Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biotechnological Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biotechnological Drugs market.
Market Segmentation:
Biotechnological Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Genetically Engineered Drugs
- Therapeutic Monoclonal Antibody Drugs
- Gene Therapy and Nucleic Acid Drugs
- Genetically Engineered Vaccines
- Other
- Tumor
- Autoimmune Disease
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- 3SBIO
- Anhui Anke Biotechnology
- Beijing SL Pharmaceutical
- Biotech Pharmaceutical
- Cadila Healthcare
- Celgen Biopharma
- Celltrion
- Dr Reddy’s
- GeneScience Pharmaceuticals
- Hisun Pharma
- Jiangsu Sihuan Bioengineering
- Novartis (Sandoz)
- Pfizer (Hospira)
- Shanghai Lansheng Guojian Pharmaceutical
- Shenzhen Neptunus Interlong Bio-Technique
- Tonghua Dongbao Pharmaceutical
- Torrent Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biotechnological Drugs Market Size 2019-2030
2.1.2 Biotechnological Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biotechnological Drugs Segment by Type
2.2.1 Genetically Engineered Drugs
2.2.2 Therapeutic Monoclonal Antibody Drugs
2.2.3 Gene Therapy and Nucleic Acid Drugs
2.2.4 Genetically Engineered Vaccines
2.2.5 Other
2.3 Biotechnological Drugs Market Size by Type
2.3.1 Biotechnological Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biotechnological Drugs Market Size Market Share by Type (2019-2024)
2.4 Biotechnological Drugs Segment by Application
2.4.1 Tumor
2.4.2 Autoimmune Disease
2.4.3 Other
2.5 Biotechnological Drugs Market Size by Application
2.5.1 Biotechnological Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biotechnological Drugs Market Size Market Share by Application (2019-2024)
3 BIOTECHNOLOGICAL DRUGS MARKET SIZE BY PLAYER
3.1 Biotechnological Drugs Market Size Market Share by Players
3.1.1 Global Biotechnological Drugs Revenue by Players (2019-2024)
3.1.2 Global Biotechnological Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Biotechnological Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOTECHNOLOGICAL DRUGS BY REGIONS
4.1 Biotechnological Drugs Market Size by Regions (2019-2024)
4.2 Americas Biotechnological Drugs Market Size Growth (2019-2024)
4.3 APAC Biotechnological Drugs Market Size Growth (2019-2024)
4.4 Europe Biotechnological Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Biotechnological Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biotechnological Drugs Market Size by Country (2019-2024)
5.2 Americas Biotechnological Drugs Market Size by Type (2019-2024)
5.3 Americas Biotechnological Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biotechnological Drugs Market Size by Region (2019-2024)
6.2 APAC Biotechnological Drugs Market Size by Type (2019-2024)
6.3 APAC Biotechnological Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biotechnological Drugs by Country (2019-2024)
7.2 Europe Biotechnological Drugs Market Size by Type (2019-2024)
7.3 Europe Biotechnological Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biotechnological Drugs by Region (2019-2024)
8.2 Middle East & Africa Biotechnological Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Biotechnological Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOTECHNOLOGICAL DRUGS MARKET FORECAST
10.1 Global Biotechnological Drugs Forecast by Regions (2025-2030)
10.1.1 Global Biotechnological Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Biotechnological Drugs Forecast
10.1.3 APAC Biotechnological Drugs Forecast
10.1.4 Europe Biotechnological Drugs Forecast
10.1.5 Middle East & Africa Biotechnological Drugs Forecast
10.2 Americas Biotechnological Drugs Forecast by Country (2025-2030)
10.2.1 United States Biotechnological Drugs Market Forecast
10.2.2 Canada Biotechnological Drugs Market Forecast
10.2.3 Mexico Biotechnological Drugs Market Forecast
10.2.4 Brazil Biotechnological Drugs Market Forecast
10.3 APAC Biotechnological Drugs Forecast by Region (2025-2030)
10.3.1 China Biotechnological Drugs Market Forecast
10.3.2 Japan Biotechnological Drugs Market Forecast
10.3.3 Korea Biotechnological Drugs Market Forecast
10.3.4 Southeast Asia Biotechnological Drugs Market Forecast
10.3.5 India Biotechnological Drugs Market Forecast
10.3.6 Australia Biotechnological Drugs Market Forecast
10.4 Europe Biotechnological Drugs Forecast by Country (2025-2030)
10.4.1 Germany Biotechnological Drugs Market Forecast
10.4.2 France Biotechnological Drugs Market Forecast
10.4.3 UK Biotechnological Drugs Market Forecast
10.4.4 Italy Biotechnological Drugs Market Forecast
10.4.5 Russia Biotechnological Drugs Market Forecast
10.5 Middle East & Africa Biotechnological Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Biotechnological Drugs Market Forecast
10.5.2 South Africa Biotechnological Drugs Market Forecast
10.5.3 Israel Biotechnological Drugs Market Forecast
10.5.4 Turkey Biotechnological Drugs Market Forecast
10.5.5 GCC Countries Biotechnological Drugs Market Forecast
10.6 Global Biotechnological Drugs Forecast by Type (2025-2030)
10.7 Global Biotechnological Drugs Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 3SBIO
11.1.1 3SBIO Company Information
11.1.2 3SBIO Biotechnological Drugs Product Offered
11.1.3 3SBIO Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 3SBIO Main Business Overview
11.1.5 3SBIO Latest Developments
11.2 Anhui Anke Biotechnology
11.2.1 Anhui Anke Biotechnology Company Information
11.2.2 Anhui Anke Biotechnology Biotechnological Drugs Product Offered
11.2.3 Anhui Anke Biotechnology Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Anhui Anke Biotechnology Main Business Overview
11.2.5 Anhui Anke Biotechnology Latest Developments
11.3 Beijing SL Pharmaceutical
11.3.1 Beijing SL Pharmaceutical Company Information
11.3.2 Beijing SL Pharmaceutical Biotechnological Drugs Product Offered
11.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Beijing SL Pharmaceutical Main Business Overview
11.3.5 Beijing SL Pharmaceutical Latest Developments
11.4 Biotech Pharmaceutical
11.4.1 Biotech Pharmaceutical Company Information
11.4.2 Biotech Pharmaceutical Biotechnological Drugs Product Offered
11.4.3 Biotech Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Biotech Pharmaceutical Main Business Overview
11.4.5 Biotech Pharmaceutical Latest Developments
11.5 Cadila Healthcare
11.5.1 Cadila Healthcare Company Information
11.5.2 Cadila Healthcare Biotechnological Drugs Product Offered
11.5.3 Cadila Healthcare Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cadila Healthcare Main Business Overview
11.5.5 Cadila Healthcare Latest Developments
11.6 Celgen Biopharma
11.6.1 Celgen Biopharma Company Information
11.6.2 Celgen Biopharma Biotechnological Drugs Product Offered
11.6.3 Celgen Biopharma Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Celgen Biopharma Main Business Overview
11.6.5 Celgen Biopharma Latest Developments
11.7 Celltrion
11.7.1 Celltrion Company Information
11.7.2 Celltrion Biotechnological Drugs Product Offered
11.7.3 Celltrion Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Celltrion Main Business Overview
11.7.5 Celltrion Latest Developments
11.8 Dr Reddy’s
11.8.1 Dr Reddy’s Company Information
11.8.2 Dr Reddy’s Biotechnological Drugs Product Offered
11.8.3 Dr Reddy’s Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Dr Reddy’s Main Business Overview
11.8.5 Dr Reddy’s Latest Developments
11.9 GeneScience Pharmaceuticals
11.9.1 GeneScience Pharmaceuticals Company Information
11.9.2 GeneScience Pharmaceuticals Biotechnological Drugs Product Offered
11.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 GeneScience Pharmaceuticals Main Business Overview
11.9.5 GeneScience Pharmaceuticals Latest Developments
11.10 Hisun Pharma
11.10.1 Hisun Pharma Company Information
11.10.2 Hisun Pharma Biotechnological Drugs Product Offered
11.10.3 Hisun Pharma Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Hisun Pharma Main Business Overview
11.10.5 Hisun Pharma Latest Developments
11.11 Jiangsu Sihuan Bioengineering
11.11.1 Jiangsu Sihuan Bioengineering Company Information
11.11.2 Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Offered
11.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Jiangsu Sihuan Bioengineering Main Business Overview
11.11.5 Jiangsu Sihuan Bioengineering Latest Developments
11.12 Novartis (Sandoz)
11.12.1 Novartis (Sandoz) Company Information
11.12.2 Novartis (Sandoz) Biotechnological Drugs Product Offered
11.12.3 Novartis (Sandoz) Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Novartis (Sandoz) Main Business Overview
11.12.5 Novartis (Sandoz) Latest Developments
11.13 Pfizer (Hospira)
11.13.1 Pfizer (Hospira) Company Information
11.13.2 Pfizer (Hospira) Biotechnological Drugs Product Offered
11.13.3 Pfizer (Hospira) Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Pfizer (Hospira) Main Business Overview
11.13.5 Pfizer (Hospira) Latest Developments
11.14 Shanghai Lansheng Guojian Pharmaceutical
11.14.1 Shanghai Lansheng Guojian Pharmaceutical Company Information
11.14.2 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Offered
11.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Shanghai Lansheng Guojian Pharmaceutical Main Business Overview
11.14.5 Shanghai Lansheng Guojian Pharmaceutical Latest Developments
11.15 Shenzhen Neptunus Interlong Bio-Technique
11.15.1 Shenzhen Neptunus Interlong Bio-Technique Company Information
11.15.2 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Offered
11.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Shenzhen Neptunus Interlong Bio-Technique Main Business Overview
11.15.5 Shenzhen Neptunus Interlong Bio-Technique Latest Developments
11.16 Tonghua Dongbao Pharmaceutical
11.16.1 Tonghua Dongbao Pharmaceutical Company Information
11.16.2 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Offered
11.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Tonghua Dongbao Pharmaceutical Main Business Overview
11.16.5 Tonghua Dongbao Pharmaceutical Latest Developments
11.17 Torrent Pharmaceuticals
11.17.1 Torrent Pharmaceuticals Company Information
11.17.2 Torrent Pharmaceuticals Biotechnological Drugs Product Offered
11.17.3 Torrent Pharmaceuticals Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Torrent Pharmaceuticals Main Business Overview
11.17.5 Torrent Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biotechnological Drugs Market Size 2019-2030
2.1.2 Biotechnological Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biotechnological Drugs Segment by Type
2.2.1 Genetically Engineered Drugs
2.2.2 Therapeutic Monoclonal Antibody Drugs
2.2.3 Gene Therapy and Nucleic Acid Drugs
2.2.4 Genetically Engineered Vaccines
2.2.5 Other
2.3 Biotechnological Drugs Market Size by Type
2.3.1 Biotechnological Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biotechnological Drugs Market Size Market Share by Type (2019-2024)
2.4 Biotechnological Drugs Segment by Application
2.4.1 Tumor
2.4.2 Autoimmune Disease
2.4.3 Other
2.5 Biotechnological Drugs Market Size by Application
2.5.1 Biotechnological Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biotechnological Drugs Market Size Market Share by Application (2019-2024)
3 BIOTECHNOLOGICAL DRUGS MARKET SIZE BY PLAYER
3.1 Biotechnological Drugs Market Size Market Share by Players
3.1.1 Global Biotechnological Drugs Revenue by Players (2019-2024)
3.1.2 Global Biotechnological Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Biotechnological Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOTECHNOLOGICAL DRUGS BY REGIONS
4.1 Biotechnological Drugs Market Size by Regions (2019-2024)
4.2 Americas Biotechnological Drugs Market Size Growth (2019-2024)
4.3 APAC Biotechnological Drugs Market Size Growth (2019-2024)
4.4 Europe Biotechnological Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Biotechnological Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biotechnological Drugs Market Size by Country (2019-2024)
5.2 Americas Biotechnological Drugs Market Size by Type (2019-2024)
5.3 Americas Biotechnological Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biotechnological Drugs Market Size by Region (2019-2024)
6.2 APAC Biotechnological Drugs Market Size by Type (2019-2024)
6.3 APAC Biotechnological Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biotechnological Drugs by Country (2019-2024)
7.2 Europe Biotechnological Drugs Market Size by Type (2019-2024)
7.3 Europe Biotechnological Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biotechnological Drugs by Region (2019-2024)
8.2 Middle East & Africa Biotechnological Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Biotechnological Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOTECHNOLOGICAL DRUGS MARKET FORECAST
10.1 Global Biotechnological Drugs Forecast by Regions (2025-2030)
10.1.1 Global Biotechnological Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Biotechnological Drugs Forecast
10.1.3 APAC Biotechnological Drugs Forecast
10.1.4 Europe Biotechnological Drugs Forecast
10.1.5 Middle East & Africa Biotechnological Drugs Forecast
10.2 Americas Biotechnological Drugs Forecast by Country (2025-2030)
10.2.1 United States Biotechnological Drugs Market Forecast
10.2.2 Canada Biotechnological Drugs Market Forecast
10.2.3 Mexico Biotechnological Drugs Market Forecast
10.2.4 Brazil Biotechnological Drugs Market Forecast
10.3 APAC Biotechnological Drugs Forecast by Region (2025-2030)
10.3.1 China Biotechnological Drugs Market Forecast
10.3.2 Japan Biotechnological Drugs Market Forecast
10.3.3 Korea Biotechnological Drugs Market Forecast
10.3.4 Southeast Asia Biotechnological Drugs Market Forecast
10.3.5 India Biotechnological Drugs Market Forecast
10.3.6 Australia Biotechnological Drugs Market Forecast
10.4 Europe Biotechnological Drugs Forecast by Country (2025-2030)
10.4.1 Germany Biotechnological Drugs Market Forecast
10.4.2 France Biotechnological Drugs Market Forecast
10.4.3 UK Biotechnological Drugs Market Forecast
10.4.4 Italy Biotechnological Drugs Market Forecast
10.4.5 Russia Biotechnological Drugs Market Forecast
10.5 Middle East & Africa Biotechnological Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Biotechnological Drugs Market Forecast
10.5.2 South Africa Biotechnological Drugs Market Forecast
10.5.3 Israel Biotechnological Drugs Market Forecast
10.5.4 Turkey Biotechnological Drugs Market Forecast
10.5.5 GCC Countries Biotechnological Drugs Market Forecast
10.6 Global Biotechnological Drugs Forecast by Type (2025-2030)
10.7 Global Biotechnological Drugs Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 3SBIO
11.1.1 3SBIO Company Information
11.1.2 3SBIO Biotechnological Drugs Product Offered
11.1.3 3SBIO Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 3SBIO Main Business Overview
11.1.5 3SBIO Latest Developments
11.2 Anhui Anke Biotechnology
11.2.1 Anhui Anke Biotechnology Company Information
11.2.2 Anhui Anke Biotechnology Biotechnological Drugs Product Offered
11.2.3 Anhui Anke Biotechnology Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Anhui Anke Biotechnology Main Business Overview
11.2.5 Anhui Anke Biotechnology Latest Developments
11.3 Beijing SL Pharmaceutical
11.3.1 Beijing SL Pharmaceutical Company Information
11.3.2 Beijing SL Pharmaceutical Biotechnological Drugs Product Offered
11.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Beijing SL Pharmaceutical Main Business Overview
11.3.5 Beijing SL Pharmaceutical Latest Developments
11.4 Biotech Pharmaceutical
11.4.1 Biotech Pharmaceutical Company Information
11.4.2 Biotech Pharmaceutical Biotechnological Drugs Product Offered
11.4.3 Biotech Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Biotech Pharmaceutical Main Business Overview
11.4.5 Biotech Pharmaceutical Latest Developments
11.5 Cadila Healthcare
11.5.1 Cadila Healthcare Company Information
11.5.2 Cadila Healthcare Biotechnological Drugs Product Offered
11.5.3 Cadila Healthcare Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cadila Healthcare Main Business Overview
11.5.5 Cadila Healthcare Latest Developments
11.6 Celgen Biopharma
11.6.1 Celgen Biopharma Company Information
11.6.2 Celgen Biopharma Biotechnological Drugs Product Offered
11.6.3 Celgen Biopharma Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Celgen Biopharma Main Business Overview
11.6.5 Celgen Biopharma Latest Developments
11.7 Celltrion
11.7.1 Celltrion Company Information
11.7.2 Celltrion Biotechnological Drugs Product Offered
11.7.3 Celltrion Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Celltrion Main Business Overview
11.7.5 Celltrion Latest Developments
11.8 Dr Reddy’s
11.8.1 Dr Reddy’s Company Information
11.8.2 Dr Reddy’s Biotechnological Drugs Product Offered
11.8.3 Dr Reddy’s Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Dr Reddy’s Main Business Overview
11.8.5 Dr Reddy’s Latest Developments
11.9 GeneScience Pharmaceuticals
11.9.1 GeneScience Pharmaceuticals Company Information
11.9.2 GeneScience Pharmaceuticals Biotechnological Drugs Product Offered
11.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 GeneScience Pharmaceuticals Main Business Overview
11.9.5 GeneScience Pharmaceuticals Latest Developments
11.10 Hisun Pharma
11.10.1 Hisun Pharma Company Information
11.10.2 Hisun Pharma Biotechnological Drugs Product Offered
11.10.3 Hisun Pharma Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Hisun Pharma Main Business Overview
11.10.5 Hisun Pharma Latest Developments
11.11 Jiangsu Sihuan Bioengineering
11.11.1 Jiangsu Sihuan Bioengineering Company Information
11.11.2 Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Offered
11.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Jiangsu Sihuan Bioengineering Main Business Overview
11.11.5 Jiangsu Sihuan Bioengineering Latest Developments
11.12 Novartis (Sandoz)
11.12.1 Novartis (Sandoz) Company Information
11.12.2 Novartis (Sandoz) Biotechnological Drugs Product Offered
11.12.3 Novartis (Sandoz) Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Novartis (Sandoz) Main Business Overview
11.12.5 Novartis (Sandoz) Latest Developments
11.13 Pfizer (Hospira)
11.13.1 Pfizer (Hospira) Company Information
11.13.2 Pfizer (Hospira) Biotechnological Drugs Product Offered
11.13.3 Pfizer (Hospira) Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Pfizer (Hospira) Main Business Overview
11.13.5 Pfizer (Hospira) Latest Developments
11.14 Shanghai Lansheng Guojian Pharmaceutical
11.14.1 Shanghai Lansheng Guojian Pharmaceutical Company Information
11.14.2 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Offered
11.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Shanghai Lansheng Guojian Pharmaceutical Main Business Overview
11.14.5 Shanghai Lansheng Guojian Pharmaceutical Latest Developments
11.15 Shenzhen Neptunus Interlong Bio-Technique
11.15.1 Shenzhen Neptunus Interlong Bio-Technique Company Information
11.15.2 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Offered
11.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Shenzhen Neptunus Interlong Bio-Technique Main Business Overview
11.15.5 Shenzhen Neptunus Interlong Bio-Technique Latest Developments
11.16 Tonghua Dongbao Pharmaceutical
11.16.1 Tonghua Dongbao Pharmaceutical Company Information
11.16.2 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Offered
11.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Tonghua Dongbao Pharmaceutical Main Business Overview
11.16.5 Tonghua Dongbao Pharmaceutical Latest Developments
11.17 Torrent Pharmaceuticals
11.17.1 Torrent Pharmaceuticals Company Information
11.17.2 Torrent Pharmaceuticals Biotechnological Drugs Product Offered
11.17.3 Torrent Pharmaceuticals Biotechnological Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Torrent Pharmaceuticals Main Business Overview
11.17.5 Torrent Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biotechnological Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Genetically Engineered Drugs
Table 3. Major Players of Therapeutic Monoclonal Antibody Drugs
Table 4. Major Players of Gene Therapy and Nucleic Acid Drugs
Table 5. Major Players of Genetically Engineered Vaccines
Table 6. Major Players of Other
Table 7. Biotechnological Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Biotechnological Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Biotechnological Drugs Market Size Market Share by Type (2019-2024)
Table 10. Biotechnological Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Biotechnological Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Biotechnological Drugs Market Size Market Share by Application (2019-2024)
Table 13. Global Biotechnological Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Biotechnological Drugs Revenue Market Share by Player (2019-2024)
Table 15. Biotechnological Drugs Key Players Head office and Products Offered
Table 16. Biotechnological Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biotechnological Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Biotechnological Drugs Market Size Market Share by Regions (2019-2024)
Table 21. Global Biotechnological Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Biotechnological Drugs Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Biotechnological Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Biotechnological Drugs Market Size Market Share by Country (2019-2024)
Table 25. Americas Biotechnological Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Biotechnological Drugs Market Size Market Share by Type (2019-2024)
Table 27. Americas Biotechnological Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Biotechnological Drugs Market Size Market Share by Application (2019-2024)
Table 29. APAC Biotechnological Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Biotechnological Drugs Market Size Market Share by Region (2019-2024)
Table 31. APAC Biotechnological Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Biotechnological Drugs Market Size Market Share by Type (2019-2024)
Table 33. APAC Biotechnological Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Biotechnological Drugs Market Size Market Share by Application (2019-2024)
Table 35. Europe Biotechnological Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Biotechnological Drugs Market Size Market Share by Country (2019-2024)
Table 37. Europe Biotechnological Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Biotechnological Drugs Market Size Market Share by Type (2019-2024)
Table 39. Europe Biotechnological Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Biotechnological Drugs Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Biotechnological Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Biotechnological Drugs Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Biotechnological Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Biotechnological Drugs Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Biotechnological Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Biotechnological Drugs Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Biotechnological Drugs
Table 48. Key Market Challenges & Risks of Biotechnological Drugs
Table 49. Key Industry Trends of Biotechnological Drugs
Table 50. Global Biotechnological Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Biotechnological Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Biotechnological Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Biotechnological Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. 3SBIO Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 55. 3SBIO Biotechnological Drugs Product Offered
Table 56. 3SBIO Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. 3SBIO Main Business
Table 58. 3SBIO Latest Developments
Table 59. Anhui Anke Biotechnology Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 60. Anhui Anke Biotechnology Biotechnological Drugs Product Offered
Table 61. Anhui Anke Biotechnology Main Business
Table 62. Anhui Anke Biotechnology Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Anhui Anke Biotechnology Latest Developments
Table 64. Beijing SL Pharmaceutical Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 65. Beijing SL Pharmaceutical Biotechnological Drugs Product Offered
Table 66. Beijing SL Pharmaceutical Main Business
Table 67. Beijing SL Pharmaceutical Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Beijing SL Pharmaceutical Latest Developments
Table 69. Biotech Pharmaceutical Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 70. Biotech Pharmaceutical Biotechnological Drugs Product Offered
Table 71. Biotech Pharmaceutical Main Business
Table 72. Biotech Pharmaceutical Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Biotech Pharmaceutical Latest Developments
Table 74. Cadila Healthcare Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 75. Cadila Healthcare Biotechnological Drugs Product Offered
Table 76. Cadila Healthcare Main Business
Table 77. Cadila Healthcare Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Cadila Healthcare Latest Developments
Table 79. Celgen Biopharma Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 80. Celgen Biopharma Biotechnological Drugs Product Offered
Table 81. Celgen Biopharma Main Business
Table 82. Celgen Biopharma Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Celgen Biopharma Latest Developments
Table 84. Celltrion Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 85. Celltrion Biotechnological Drugs Product Offered
Table 86. Celltrion Main Business
Table 87. Celltrion Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Celltrion Latest Developments
Table 89. Dr Reddy’s Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 90. Dr Reddy’s Biotechnological Drugs Product Offered
Table 91. Dr Reddy’s Main Business
Table 92. Dr Reddy’s Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Dr Reddy’s Latest Developments
Table 94. GeneScience Pharmaceuticals Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 95. GeneScience Pharmaceuticals Biotechnological Drugs Product Offered
Table 96. GeneScience Pharmaceuticals Main Business
Table 97. GeneScience Pharmaceuticals Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. GeneScience Pharmaceuticals Latest Developments
Table 99. Hisun Pharma Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 100. Hisun Pharma Biotechnological Drugs Product Offered
Table 101. Hisun Pharma Main Business
Table 102. Hisun Pharma Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Hisun Pharma Latest Developments
Table 104. Jiangsu Sihuan Bioengineering Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 105. Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Offered
Table 106. Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Jiangsu Sihuan Bioengineering Main Business
Table 108. Jiangsu Sihuan Bioengineering Latest Developments
Table 109. Novartis (Sandoz) Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 110. Novartis (Sandoz) Biotechnological Drugs Product Offered
Table 111. Novartis (Sandoz) Main Business
Table 112. Novartis (Sandoz) Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Novartis (Sandoz) Latest Developments
Table 114. Pfizer (Hospira) Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 115. Pfizer (Hospira) Biotechnological Drugs Product Offered
Table 116. Pfizer (Hospira) Main Business
Table 117. Pfizer (Hospira) Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Pfizer (Hospira) Latest Developments
Table 119. Shanghai Lansheng Guojian Pharmaceutical Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 120. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Offered
Table 121. Shanghai Lansheng Guojian Pharmaceutical Main Business
Table 122. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Shanghai Lansheng Guojian Pharmaceutical Latest Developments
Table 124. Shenzhen Neptunus Interlong Bio-Technique Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 125. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Offered
Table 126. Shenzhen Neptunus Interlong Bio-Technique Main Business
Table 127. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Shenzhen Neptunus Interlong Bio-Technique Latest Developments
Table 129. Tonghua Dongbao Pharmaceutical Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 130. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Offered
Table 131. Tonghua Dongbao Pharmaceutical Main Business
Table 132. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Tonghua Dongbao Pharmaceutical Latest Developments
Table 134. Torrent Pharmaceuticals Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 135. Torrent Pharmaceuticals Biotechnological Drugs Product Offered
Table 136. Torrent Pharmaceuticals Main Business
Table 137. Torrent Pharmaceuticals Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Torrent Pharmaceuticals Latest Developments
Table 1. Biotechnological Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Genetically Engineered Drugs
Table 3. Major Players of Therapeutic Monoclonal Antibody Drugs
Table 4. Major Players of Gene Therapy and Nucleic Acid Drugs
Table 5. Major Players of Genetically Engineered Vaccines
Table 6. Major Players of Other
Table 7. Biotechnological Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Biotechnological Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Biotechnological Drugs Market Size Market Share by Type (2019-2024)
Table 10. Biotechnological Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Biotechnological Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Biotechnological Drugs Market Size Market Share by Application (2019-2024)
Table 13. Global Biotechnological Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Biotechnological Drugs Revenue Market Share by Player (2019-2024)
Table 15. Biotechnological Drugs Key Players Head office and Products Offered
Table 16. Biotechnological Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biotechnological Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Biotechnological Drugs Market Size Market Share by Regions (2019-2024)
Table 21. Global Biotechnological Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Biotechnological Drugs Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Biotechnological Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Biotechnological Drugs Market Size Market Share by Country (2019-2024)
Table 25. Americas Biotechnological Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Biotechnological Drugs Market Size Market Share by Type (2019-2024)
Table 27. Americas Biotechnological Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Biotechnological Drugs Market Size Market Share by Application (2019-2024)
Table 29. APAC Biotechnological Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Biotechnological Drugs Market Size Market Share by Region (2019-2024)
Table 31. APAC Biotechnological Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Biotechnological Drugs Market Size Market Share by Type (2019-2024)
Table 33. APAC Biotechnological Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Biotechnological Drugs Market Size Market Share by Application (2019-2024)
Table 35. Europe Biotechnological Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Biotechnological Drugs Market Size Market Share by Country (2019-2024)
Table 37. Europe Biotechnological Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Biotechnological Drugs Market Size Market Share by Type (2019-2024)
Table 39. Europe Biotechnological Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Biotechnological Drugs Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Biotechnological Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Biotechnological Drugs Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Biotechnological Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Biotechnological Drugs Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Biotechnological Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Biotechnological Drugs Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Biotechnological Drugs
Table 48. Key Market Challenges & Risks of Biotechnological Drugs
Table 49. Key Industry Trends of Biotechnological Drugs
Table 50. Global Biotechnological Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Biotechnological Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Biotechnological Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Biotechnological Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. 3SBIO Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 55. 3SBIO Biotechnological Drugs Product Offered
Table 56. 3SBIO Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. 3SBIO Main Business
Table 58. 3SBIO Latest Developments
Table 59. Anhui Anke Biotechnology Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 60. Anhui Anke Biotechnology Biotechnological Drugs Product Offered
Table 61. Anhui Anke Biotechnology Main Business
Table 62. Anhui Anke Biotechnology Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Anhui Anke Biotechnology Latest Developments
Table 64. Beijing SL Pharmaceutical Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 65. Beijing SL Pharmaceutical Biotechnological Drugs Product Offered
Table 66. Beijing SL Pharmaceutical Main Business
Table 67. Beijing SL Pharmaceutical Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Beijing SL Pharmaceutical Latest Developments
Table 69. Biotech Pharmaceutical Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 70. Biotech Pharmaceutical Biotechnological Drugs Product Offered
Table 71. Biotech Pharmaceutical Main Business
Table 72. Biotech Pharmaceutical Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Biotech Pharmaceutical Latest Developments
Table 74. Cadila Healthcare Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 75. Cadila Healthcare Biotechnological Drugs Product Offered
Table 76. Cadila Healthcare Main Business
Table 77. Cadila Healthcare Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Cadila Healthcare Latest Developments
Table 79. Celgen Biopharma Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 80. Celgen Biopharma Biotechnological Drugs Product Offered
Table 81. Celgen Biopharma Main Business
Table 82. Celgen Biopharma Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Celgen Biopharma Latest Developments
Table 84. Celltrion Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 85. Celltrion Biotechnological Drugs Product Offered
Table 86. Celltrion Main Business
Table 87. Celltrion Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Celltrion Latest Developments
Table 89. Dr Reddy’s Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 90. Dr Reddy’s Biotechnological Drugs Product Offered
Table 91. Dr Reddy’s Main Business
Table 92. Dr Reddy’s Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Dr Reddy’s Latest Developments
Table 94. GeneScience Pharmaceuticals Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 95. GeneScience Pharmaceuticals Biotechnological Drugs Product Offered
Table 96. GeneScience Pharmaceuticals Main Business
Table 97. GeneScience Pharmaceuticals Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. GeneScience Pharmaceuticals Latest Developments
Table 99. Hisun Pharma Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 100. Hisun Pharma Biotechnological Drugs Product Offered
Table 101. Hisun Pharma Main Business
Table 102. Hisun Pharma Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Hisun Pharma Latest Developments
Table 104. Jiangsu Sihuan Bioengineering Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 105. Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Offered
Table 106. Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Jiangsu Sihuan Bioengineering Main Business
Table 108. Jiangsu Sihuan Bioengineering Latest Developments
Table 109. Novartis (Sandoz) Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 110. Novartis (Sandoz) Biotechnological Drugs Product Offered
Table 111. Novartis (Sandoz) Main Business
Table 112. Novartis (Sandoz) Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Novartis (Sandoz) Latest Developments
Table 114. Pfizer (Hospira) Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 115. Pfizer (Hospira) Biotechnological Drugs Product Offered
Table 116. Pfizer (Hospira) Main Business
Table 117. Pfizer (Hospira) Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Pfizer (Hospira) Latest Developments
Table 119. Shanghai Lansheng Guojian Pharmaceutical Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 120. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Offered
Table 121. Shanghai Lansheng Guojian Pharmaceutical Main Business
Table 122. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Shanghai Lansheng Guojian Pharmaceutical Latest Developments
Table 124. Shenzhen Neptunus Interlong Bio-Technique Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 125. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Offered
Table 126. Shenzhen Neptunus Interlong Bio-Technique Main Business
Table 127. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Shenzhen Neptunus Interlong Bio-Technique Latest Developments
Table 129. Tonghua Dongbao Pharmaceutical Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 130. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Offered
Table 131. Tonghua Dongbao Pharmaceutical Main Business
Table 132. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Tonghua Dongbao Pharmaceutical Latest Developments
Table 134. Torrent Pharmaceuticals Details, Company Type, Biotechnological Drugs Area Served and Its Competitors
Table 135. Torrent Pharmaceuticals Biotechnological Drugs Product Offered
Table 136. Torrent Pharmaceuticals Main Business
Table 137. Torrent Pharmaceuticals Biotechnological Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Torrent Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Biotechnological Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biotechnological Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Biotechnological Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biotechnological Drugs Sales Market Share by Country/Region (2023)
Figure 8. Biotechnological Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biotechnological Drugs Market Size Market Share by Type in 2023
Figure 10. Biotechnological Drugs in Tumor
Figure 11. Global Biotechnological Drugs Market: Tumor (2019-2024) & ($ Millions)
Figure 12. Biotechnological Drugs in Autoimmune Disease
Figure 13. Global Biotechnological Drugs Market: Autoimmune Disease (2019-2024) & ($ Millions)
Figure 14. Biotechnological Drugs in Other
Figure 15. Global Biotechnological Drugs Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Biotechnological Drugs Market Size Market Share by Application in 2023
Figure 17. Global Biotechnological Drugs Revenue Market Share by Player in 2023
Figure 18. Global Biotechnological Drugs Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Biotechnological Drugs Market Size 2019-2024 ($ Millions)
Figure 20. APAC Biotechnological Drugs Market Size 2019-2024 ($ Millions)
Figure 21. Europe Biotechnological Drugs Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Biotechnological Drugs Market Size 2019-2024 ($ Millions)
Figure 23. Americas Biotechnological Drugs Value Market Share by Country in 2023
Figure 24. United States Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Biotechnological Drugs Market Size Market Share by Region in 2023
Figure 29. APAC Biotechnological Drugs Market Size Market Share by Type in 2023
Figure 30. APAC Biotechnological Drugs Market Size Market Share by Application in 2023
Figure 31. China Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Biotechnological Drugs Market Size Market Share by Country in 2023
Figure 38. Europe Biotechnological Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe Biotechnological Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Biotechnological Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Biotechnological Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Biotechnological Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 54. APAC Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 55. Europe Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 57. United States Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 58. Canada Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 61. China Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Japan Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 63. Korea Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 65. India Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Australia Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 67. Germany Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 68. France Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 69. UK Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Italy Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 71. Russia Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 72. Spain Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 75. Israel Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 78. Global Biotechnological Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Biotechnological Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Biotechnological Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biotechnological Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Biotechnological Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biotechnological Drugs Sales Market Share by Country/Region (2023)
Figure 8. Biotechnological Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biotechnological Drugs Market Size Market Share by Type in 2023
Figure 10. Biotechnological Drugs in Tumor
Figure 11. Global Biotechnological Drugs Market: Tumor (2019-2024) & ($ Millions)
Figure 12. Biotechnological Drugs in Autoimmune Disease
Figure 13. Global Biotechnological Drugs Market: Autoimmune Disease (2019-2024) & ($ Millions)
Figure 14. Biotechnological Drugs in Other
Figure 15. Global Biotechnological Drugs Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Biotechnological Drugs Market Size Market Share by Application in 2023
Figure 17. Global Biotechnological Drugs Revenue Market Share by Player in 2023
Figure 18. Global Biotechnological Drugs Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Biotechnological Drugs Market Size 2019-2024 ($ Millions)
Figure 20. APAC Biotechnological Drugs Market Size 2019-2024 ($ Millions)
Figure 21. Europe Biotechnological Drugs Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Biotechnological Drugs Market Size 2019-2024 ($ Millions)
Figure 23. Americas Biotechnological Drugs Value Market Share by Country in 2023
Figure 24. United States Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Biotechnological Drugs Market Size Market Share by Region in 2023
Figure 29. APAC Biotechnological Drugs Market Size Market Share by Type in 2023
Figure 30. APAC Biotechnological Drugs Market Size Market Share by Application in 2023
Figure 31. China Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Biotechnological Drugs Market Size Market Share by Country in 2023
Figure 38. Europe Biotechnological Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe Biotechnological Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Biotechnological Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Biotechnological Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Biotechnological Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Biotechnological Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 54. APAC Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 55. Europe Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 57. United States Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 58. Canada Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 61. China Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Japan Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 63. Korea Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 65. India Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Australia Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 67. Germany Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 68. France Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 69. UK Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Italy Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 71. Russia Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 72. Spain Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 75. Israel Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Biotechnological Drugs Market Size 2025-2030 ($ Millions)
Figure 78. Global Biotechnological Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Biotechnological Drugs Market Size Market Share Forecast by Application (2025-2030)
